OPSUMIT (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the OPSUMIT drug offered from Actelion Pharmaceuticals US, Inc.. This Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
NON-PROPRIETARY NAME: | macitentan |
SUBSTANCE NAME: | MACITENTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-11-04 |
END MARKETING DATE: | 0000-00-00 |
OPSUMIT HUMAN PRESCRIPTION DRUG Details:
Item Description | OPSUMIT from Actelion Pharmaceuticals US, Inc. |
LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2013-11-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66215-501_be878637-a2c5-42ea-9924-fc868d1f1323 |
PRODUCT NDC: | 66215-501 |
APPLICATION NUMBER: | NDA204410 |
Other MACITENTAN Pharmaceutical Manufacturers / Labelers: